Paul Wicks
Overview
Explore the profile of Paul Wicks including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
129
Citations
2323
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Darcy A, Beaudette A, Chiauzzi E, Daniels J, Goodwin K, Mariano T, et al.
Expert Rev Med Devices
. 2023 Nov;
20(12):1035-1049.
PMID: 37938145
Introduction: Postpartum depression (PPD) is common, persistent, and stigmatized. There are insufficient trained professionals to deliver appropriate screening, diagnosis, and treatment. Areas Covered: WB001 is a Software as a Medical...
12.
Sun Y, Benatar M, Cadavid J, Ennist D, Wicks P, Staats K, et al.
Amyotroph Lateral Scler Frontotemporal Degener
. 2023 Jul;
25(1-2):218-222.
PMID: 37493197
Nuedexta is a combination of dextromethorphan hydrobromide and quinidine sulfate and was approved by the Food and Drug Administration (FDA) in 2010 to treat pseudobulbar affect (PBA). There have since...
13.
Gilbert S, Harvey H, Melvin T, Vollebregt E, Wicks P
Nat Med
. 2023 Jun;
29(10):2396-2398.
PMID: 37391665
No abstract available.
14.
Hatch J, Barkhaus P, Barnes B, Beauchamp M, Benatar M, Bertorini T, et al.
Amyotroph Lateral Scler Frontotemporal Degener
. 2023 Jun;
:1-5.
PMID: 37288776
ALSUntangled reviews alternative and off-label treatments for people living with amyotrophic lateral sclerosis (PALS). Here, we review caffeine which has plausible mechanisms for slowing ALS progression. However, pre-clinical studies are...
15.
Lepage S, Conway A, Goodson N, Wicks P, Devane D
HRB Open Res
. 2023 Jun;
5:46.
PMID: 37274595
This scoping review will determine how online, randomised trials with children are conducted. The objectives of the review are: (a) to determine what methods and tools have been used to...
16.
Silberman J, Wicks P, Patel S, Sarlati S, Park S, Korolev I, et al.
NPJ Digit Med
. 2023 May;
6(1):101.
PMID: 37258851
Dozens of frameworks have been proposed to assess evidence for digital health interventions (DHIs), but existing frameworks may not facilitate DHI evidence reviews that meet the needs of stakeholder organizations...
17.
Lepage S, Conway A, Goodson N, Wicks P, Flight L, Devane D
PLoS One
. 2023 May;
18(5):e0280965.
PMID: 37228143
Background: Paediatric trials must contend with many challenges that adult trials face but often bring additional obstacles. Decentralised trials, where some or all trial methods occur away from a centralised...
18.
Swidler J, Olson T, Edelstein A, Granning J, Haddad C, Uhrlaub M, et al.
Brain
. 2023 May;
146(10):e77-e79.
PMID: 37202873
No abstract available.
19.
Wicks P, Wahlstrom-Edwards L, Fillingham S, Downing A, Davies E
Patient
. 2023 Mar;
16(3):183-199.
PMID: 36947286
Patient registries fulfill a number of key roles for clinicians, researchers, non-profit organizations, payers, and policy makers. They can help the field understand the natural history of a condition, determine...
20.
Fullam T, Armon C, Barkhaus P, Barnes B, Beauchamp M, Benatar M, et al.
Amyotroph Lateral Scler Frontotemporal Degener
. 2023 Jan;
24(5-6):553-557.
PMID: 36694292
ALSUntangled reviews alternative and off-label treatments for people living with amyotrophic lateral sclerosis (PALS). Here we review astaxanthin which has plausible mechanisms for slowing ALS progression including antioxidant, anti-inflammatory, and...